Inactivation of AKT, ERK and NF-κB by genistein derivative, 7-difluoromethoxyl-5,4′-di-n-octylygenistein, reduces ovarian carcinoma oncogenicity
Yingxia Ning(First Affiliated Hospital of Guangzhou Medical University), Xin Luo(First Affiliated Hospital of Jinan University)
Cited by 34
Related Papers
RETRACTED ARTICLE: Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis
|Journal of Experimental & Clinical Cancer Research|2019|58
Elevated NF-κB signaling in Asherman syndrome patients and animal models
|Oncotarget|2017|57
7-difluoromethoxyl-5,4′-di-n-octyl genistein inhibits ovarian cancer stem cell characteristics through the downregulation of FOXM1
|Oncology Letters|2014|34
Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways
|Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics|2023|33